Guías Clínicas 143 GUÍA CLÍNICA DE MANEJO Y TRATAMIENTO DE LA INFECCIÓN POR VIRUS DE LA HEPATITIS B - Ministerio de Salud, Chile cgi/news/release?id=100647. (Accedido el 30/09/2009). 39.- Muñoz M, Pino L. El 25% de los por-tadores del virus de la hepatitis B de-sarrollarán enfermedades graves como hepatitis crónica o cáncer hepático. Disponible en www.accesomedia.com/ display_release.html?id=14379. Accedido el 30/09/2009). 40.- Muñoz G. Diagnóstico serológico y virológico de la Hepatitis B y C: aspec-tos prácticos. Gastr Latinoam 2006; 17: 249-52. 41.- Idrovo, V. Hepatitis por virus B. Disponible en: http://www.higado-colombia. org/RevisionTema/default. asp?pag=revision.asp&RevisionID=14. Accedido 30/9/09. 42.- Manual de Toma de Muestras Virología. Instituto de Salud Pública. 2007. 43.- Ratnam S, Stead F, Head CB. False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay. J Clin Microbiol 1989; 27: 2102-4. 44.- Instructivo PEEC 2008 del Programa de Evaluación Externa de la Calidad 2008: 114. 45.- Sorrel MF, Belongia MA, Costa a, et al. National Institutes of Health Consensus development conference statement. Management of hepatitis B. Ann Intern Med 2009; 150: 104-10. 46.- EASL Clinical practice guidelines: Ma-nagement of chronic hepatitis B. Con-sensus conference on hepatitis B. 2008. European Association for the Study of the Liver (EASL). September 2002. Consensus statement (long version) J Hepatol 2009 (in press). 47.- Sherman M, et al. Management of chronic hepatitis B: Consensus guideli-nes. Canadian consensus guidelines. Can J Gastroenterol 2007; 21: Suppl C: 5-24. 48.- Keeffe EB, Dieterich DT, Han SB, et al. A treatment algorithm for the manage-ment of chronic hepatitis B virus infec-tion in the United States: 2008: Update. Clin Gastro Hepatol 2008; 6: 1315-41. 49.- Vigani A, et al. Consensus for the ma-nagement and treatment of hepatitis B carried out by the brasilean Society of infectious diseases. BJID 2007; 11: 2-5. 50.- Villamil F, Tanno H, Ruff AE. Docu-mento final de Consenso argentino de hepatitis B. Acta Gastroenterol Latinoam 2004; 34: 138-48. 51.- Aguilar J. Hepatitis crónica B: candida-tos al tratamiento. Necesidad de biopsia hepática. En Consenso Español para el diagnóstico y tratamiento de la hepatitis B y C. Gastroenterol Hepatol 2006; 29: 20-2. 52.- Buster EH, Van Erpecum KJ, Schalm SW, et al. Treatment of chronic hepatitis B virua infection. Dutch national guide-lines. Ned J Med 2008; 66: 292-306. 53.- Cornberg M, Protzer U, Dollinger MM, Petersen J, et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HVB) infection: the German guidelines for the management of HVB infection. Z Gastroenterol 2007; 45: 1281-328. 54.- Heathcote J, Abbas Z, Alberti A, Benhamou Y, et al. Hepatitis B. World Gastroenterology Organization Practice Guideline. September, 2008. 1-29. Dis-ponible en: http://www.worldgastroen-terology. org/assets/downloads/en/pdf/ guidelines/12_hepatitis_b_en.pdf en. Accedido el 30/9/2009. 55.- Daruich J, Gadano A, Fainboim H, Pessoa M, Cheinquer H. Guía de Tra-tamiento de la Hepatitis B Crónica (ALEH). Acta Gastroenterol Latinoam 2007; 37: 168-177. 56.- Dienstag J. Hepatitis B infection. N Engl J Med 2008; 359: 1486-500. 57.- Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a nume-rical scoring system for assessing histo-logical activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5. 58.- Hui CK, Leung N, Yuen ST, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 2007; 46: 395-401. 59.- Lai M, Hyatt BJ, Nasser I, et al. The clinical significance of persistently nor-mal ALT in chronic hepatitis B infection. J Hepatol 2007; 47: 760-7. 60.- Ayoub ES, Keeffe E. Current antiviral therapy of chronic hepatitis B. Alim Pharm Ther 2008; 28: 167-77. 61.- Ke-Kin H. A practical approach to ma-nagement of hepatitis B. Int J Med Sci 2005; 2: 17-23. 62.- Lok AS, McMahon Bj. The maze of treatments for hepatitis B. N Engl J Med 2005; 352: 1743-2746. 63.- Piratvisuth T, Jin R, Gurel S, Hadziyan-nis S, Lu ZM, Popescu M. Factors asso-ciated with sustained virologic response 1 year after treatment with peginterferon alfa-2a (40KD) Pegasys monotherapy for HBeAg-negative chronic hepatitis B. Hepatology 2005; 42 (Suppl 1): 580A. 64.- Hadziyannis SJ, Sevastianos V, Rapti IN, Tassopoulos N. Sustained biochemical and virological remission after discontiuation of 4 to 5 years of adefovir dipivoxil (ADV) treatment in HBeAg-negative chronic hepatitis B. Hepatology 2006; 44 (Suppl 1): 231-2A. 65.- Fung SK, Lok AS. Treatment of chronic hepatitis B: who to treat, what to use, and for how long? Clin Gastroenterol Hepatol 2004; 2: 839-48. 66.- Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, et al. Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol 2006; 4: 233-48. 67.- Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, et al. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 2005; 352: 2682-95. 68.- Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM. Treatment recommendations for chronic hepatitis B: An evaluation of current guidelines based on a natural history study in the United Sates. Hepa-tology; 2008; 48: 1070-1078. 69.- Tillman H, Patel K, McHutchison J. Hepatitis B virus viral load and treatment decision. Hepatology 2009; 49: 699 (letter). 70.- Velasco M, Contreras J, Poniachik J, et al. Lamivudina como terapia de la hepatitis aguda grave o insuficiencia hepática fulminante por virus de la hepa-titis B (VHB). Gastroenterol Latinoam 2004 (abstract.); 15: 293. 71.- De Jongh FE, Janssen HL, de Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-5. 72.- Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter-the investigators of Gastroenterol. latinoam 2010; Vol 21, Nº 2: 89-147
n1-2010
To see the actual publication please follow the link above